1Relationship between polymorphisms of thymidylate synthase and methyle-netetrahydrofolate reductase and susceptibility in Liaoning Benxi colorectal cancer pafientsARTICLES769-773
2VEGF expression and lymphocytes infiltrating in the prognosis of nasophary-geal carcinomaARTICLES774-778
5The expression and clinical significance of survivin,pS3 and p21 in the non-small cell lung cancerARTICLES788-791
6Relationship between expression of multidrug resistance protein,PCNA and p53 and its significance in patients with non-small cell lung cancerARTICLES792-796
7Endostar combined with TP or GP regimen in advanced non-small cell lung cancer patientsARTICLES797-799
8Clinical observation on low dose of tegafur tablits by oral administration for advanced non-small cell lung cancer patientsARTICLES800-802
9Clinical observation of weekly dose doctaxale in the treatment of elderly patients with non-small cell lung cancerARTICLES803-805
10Gemcitabine and carboplatin in the treatment of elderly patients with advanced non-small cell lung cancerARTICLES806-808
11Study of toxicity and radiosensitizing effect of semi-artificial synthetic chiral docetaxel on human lung adenocarcinoma cell line A549.ARTICLES809-812
13Clinical significance of vascular endothelial growth factor expression on postoperative adjuvant radiotherapy in esophageal carcinomaARTICLES817-820
14Clinical observation of semimonthly 5-fluorouracil and leucovorin combined with paclitaxel and oxaliplatin in advanced gastric cancerARTICLES821-824
15Treatment for middle and advanced stage of bladder cancer through intra-internal iliac artery infusion chemotherapyARTICLES825-827
16Results of flexible 3D-conformal radiotherapy for patients with diffuse malignant pleural mesothelioma and comparative study of this technique with conventional radiotherapyARTICLES828-831
17Influence of aloe-emodin on Fas ligand gene expression and invasive ability of human colon cancer cellsARTICLES832-835
18Clinical observation of individualizational controlled-release oxycodone in the treatment of outpatients with moderate-to-severe cancer painARTICLES836-838
